Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1953 1
1954 1
1955 1
1959 1
1962 1
1963 1
1964 2
1965 4
1966 11
1967 3
1968 4
1969 4
1970 3
1971 5
1972 1
1973 1
1974 6
1975 7
1976 6
1977 7
1978 6
1979 9
1980 5
1981 13
1982 8
1983 7
1984 10
1985 10
1986 14
1987 22
1988 7
1989 16
1990 21
1991 16
1992 22
1993 25
1994 28
1995 25
1996 30
1997 23
1998 26
1999 35
2000 36
2001 36
2002 37
2003 40
2004 40
2005 55
2006 49
2007 48
2008 79
2009 83
2010 58
2011 77
2012 78
2013 77
2014 83
2015 75
2016 68
2017 74
2018 90
2019 94
2020 112
2021 112
2022 96
2023 98
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

1,960 results

Results by year

Filters applied: . Clear all
Page 1
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. Wallace ZS, et al. Among authors: okazaki k. Arthritis Rheumatol. 2020 Jan;72(1):7-19. doi: 10.1002/art.41120. Epub 2019 Dec 2. Arthritis Rheumatol. 2020. PMID: 31793250
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. Wallace ZS, et al. Among authors: okazaki k. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561. Epub 2019 Dec 3. Ann Rheum Dis. 2020. PMID: 31796497 Review.
Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020.
Okazaki K, Kawa S, Kamisawa T, Ikeura T, Itoi T, Ito T, Inui K, Irisawa A, Uchida K, Ohara H, Kubota K, Kodama Y, Shimizu K, Tonozuka R, Nakazawa T, Nishino T, Notohara K, Fujinaga Y, Masamune A, Yamamoto H, Watanabe T, Nishiyama T, Kawano M, Shiratori K, Shimosegawa T, Takeyama Y; Members of the Research Committee for IgG4-related Disease supported by the Ministry of Health, Labour, Welfare of Japan, Japan Pancreas Society. Okazaki K, et al. J Gastroenterol. 2022 Apr;57(4):225-245. doi: 10.1007/s00535-022-01857-9. Epub 2022 Feb 22. J Gastroenterol. 2022. PMID: 35192048 Free PMC article. Review.
The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD.
Umehara H, Okazaki K, Kawa S, Takahashi H, Goto H, Matsui S, Ishizaka N, Akamizu T, Sato Y, Kawano M; Research Program for Intractable Disease by the Ministry of Health, Labor and Welfare (MHLW) Japan.. Umehara H, et al. Among authors: okazaki k. Mod Rheumatol. 2021 May;31(3):529-533. doi: 10.1080/14397595.2020.1859710. Epub 2021 Jan 28. Mod Rheumatol. 2021. PMID: 33274670
Clinical practice guidelines for IgG4-related sclerosing cholangitis.
Kamisawa T, Nakazawa T, Tazuma S, Zen Y, Tanaka A, Ohara H, Muraki T, Inui K, Inoue D, Nishino T, Naitoh I, Itoi T, Notohara K, Kanno A, Kubota K, Hirano K, Isayama H, Shimizu K, Tsuyuguchi T, Shimosegawa T, Kawa S, Chiba T, Okazaki K, Takikawa H, Kimura W, Unno M, Yoshida M. Kamisawa T, et al. Among authors: okazaki k. J Hepatobiliary Pancreat Sci. 2019 Jan;26(1):9-42. doi: 10.1002/jhbp.596. Epub 2019 Jan 18. J Hepatobiliary Pancreat Sci. 2019. PMID: 30575336 Free PMC article.
NRF2 signalling in cytoprotection and metabolism.
Murakami S, Kusano Y, Okazaki K, Akaike T, Motohashi H. Murakami S, et al. Among authors: okazaki k. Br J Pharmacol. 2023 Sep 15. doi: 10.1111/bph.16246. Online ahead of print. Br J Pharmacol. 2023. PMID: 37715470 Review.
Nonresponder Considerations for Romosozumab Treatment.
Tominaga A, Wada K, Okazaki K, Nishi H, Terayama Y, Shimamoto S, Kodama Y, Kato Y. Tominaga A, et al. Among authors: okazaki k. Calcif Tissue Int. 2023 Aug;113(2):157-165. doi: 10.1007/s00223-023-01087-y. Epub 2023 May 3. Calcif Tissue Int. 2023. PMID: 37138124
Advances in IgG4-related pancreatobiliary diseases.
Kamisawa T, Zen Y, Nakazawa T, Okazaki K. Kamisawa T, et al. Among authors: okazaki k. Lancet Gastroenterol Hepatol. 2018 Aug;3(8):575-585. doi: 10.1016/S2468-1253(18)30121-3. Lancet Gastroenterol Hepatol. 2018. PMID: 30047448 Review.
1,960 results